Navigation Links
MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
Date:1/18/2008

Daiichi Sankyo, Inc. announced today that the United States Food and Drug Administration (FDA) has approved WelChol(R) (colesevelam HCl) Tablets as the first LDL cholesterol lowering medication also indicated for improving glycemic control in adults with type 2 diabetes mellitus (DM) in combination with metformin, sulfonylureas, or insulin, when these agents are used alone or in combination with other anti-diabetic agents.

The ADA estimates that 20.8 million people in the United States have diabetes and more than 90% of these have type 2 diabetes. People with diabetes face significantly higher risk of developing cardiovascular disease. It is estimated that approximately half of all Americans have elevated blood cholesterol levels that can negatively impact their health and quality of life. According to a recent Harris Interactive Survey, approximately 29% of adults previously diagnosed with hypercholesterolemia have also been diagnosed with diabetes. Given the prevalence of diabetes and high LDL cholesterol, a medication that can help lower both A1C and LDL cholesterol can be beneficial for many patients. Welchol is a new option that addresses these two chronic health conditions and provides physicians with a different therapeutic approach for treating patients with type 2 diabetes.
For more information, please visit http://www.dsus.com.

SATELLITE FEED:

Friday, January 18th, 2008

6:30 PM - 6:45 PM ET

Galaxy 25

C-Band

Transponder 14

Downlink Freq. 3980 Horizontal

Preview and access this video on Pathfire DMG: Slug # 29711

Search within the PR Newswire or MultiVu section by story ID # 29711 or by headline

For technical assistance call Pathfire Customer Care at 1-888-345-0489 or e-mail support@pathfire.com

NEWS: WelChol Receives FDA Approval To Reduce Blood Glucose in Adults with Type 2
'/>"/>

SOURCE Daiichi Sankyo
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
2. MultiVu Video Feed: NEW SURVEY FINDS THAT HALF OF CAREGIVERS SPEND 10 PERCENT OF THEIR INCOME CARING FOR AN OLDER LOVED ONE
3. MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS
4. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
5. MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections
6. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
7. VIDEO from Medialink and The Leukemia & Lymphoma Society: Saving Lives One Mile at a Time
8. VIDEO from Medialink and Stryker: New Alternative to Hip Replacement Surgery
9. InfoLogix Featured in FOX Business News Interview on Reducing Healthcare Medication Errors - Video Available Online
10. VIDEO from Medialink and Revolution Health: RevolutionHealth.com Launches Resolutions 2.0
11. VIDEO from Medialink and GlaxoSmithKline: Really Think You Can Lose 30 Pounds in 30 Days?

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...cal, economic burdens, study predicts , ,...f people with diabetes in the United States is exp...y predicts. , That would bring the total by 203...p from 23.7 million today. , , At the same time,...iple, the study also warns, rising from an estimat...
(Date:11/27/2009)...rade; announced today that Spectrum Health (Grand ...prise orthopedic templating solution and its Traum... (PRWEB) November 27, 2009 -- Voyant Health...d Rapids, Michigan) has licensed its TraumaCad Ent...umaCad Extend workflow solution, to allow its orth...
(Date:11/27/2009)...facturers who use medical load cells at the heart ...y bringing in technology partner Flintec early in ...ve medical manufacturers are calling in Flintec lo...ects, ensuring that progress will not be constrain...dated technology. , (PRWE...
(Date:11/26/2009).../ -- With cold and flu season upon us, it,s more i...trol the spread of infections and avoid illness. ,...selves healthy, but to avoid transmitting illness ...certified in infection-control), nursing director ...ospital for Special Surgery (HSS) in Manhattan. ,...
(Date:11/26/2009)...ricans living with diabetes will nearly double, in... in 2034. Over the same period, spending on diabet... $336 billion, even with no increase in the preval...ty of Chicago report in the December issue of Dia... covered by Medicare will rise from 8.2 million to...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
... ones neighborhood are associated with greater ast...g to researchers in Vancouver, Canada. , Social e...t factor in asthma manifestations in youth, but fe...n, Ph.D., of the University of British Columbia, a...
...P, FACEP (E) Executive Director ...ept. 27 "During a press event,yesterday aimed at ... Child,Left Behind Act, President Bush stated that...on his desk. The bipartisan,legislation, a result ...
...e Help of a Registered Dietitian, SAN BERNARDINO,...ce a new program designed to broaden the company,s... called "Healthy Selections." (Photo: http://www...rogram will educate and encourage,customers to mak...
...O,Alan P. Spielman presented testimony Sept. 26 ab...agement and Drug Therapy Management standards to,a... on Executive,Departments and Administration. (LO...ulate the practice of pharmacy benefit management ...
...nown as avian influenza, is considered a major glo...es. While little had been known about the specifi...the virus, researchers at Beijing University, Colu...1 victims that shed light on the anatomic distribu...
...ia types, its,hard not to notice that Britney has ...m all indications, something is definitely going o..., a patient came in recently for a dental,cosmetic... that pile was ... you guessed it, "Britney Spears...
Other Medicine News:Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 2Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 3Health News:APHA Urges President Bush Not To Veto CHIP; 'We're Only One Signature Away from Protecting the Health of Our Children' 2Health News:Stater Bros. Introduces New 'Healthy Selections' Dietitian Program 2Health News:URAC CEO Testifies Before New Hampshire Legislators Regarding New URAC Standards for Pharmacy Benefit Management 2Health News:New research shows how H5N1 virus causes disease 2
(Date:11/25/2009)..., LOVELAND, Colo., Nov. 25 /PRNewswire-FirstCal...ing provider of advanced diagnostic and specialt...oday agreements with Roche Diagnostics Corporation...ed consumables for the veterinary market. ,,...0622/HESKALOGO ) ,, "Heska and Roche share the ...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-FirstCall.... Michael J. McKelvey, the Company,s President and...ice President and CFO, are scheduled to present at...nce at 1:30 PM EST on December 1, 2009 in New York...ss the presentation by visiting the Company,s corp...
(Date:11/25/2009)... BRIDGEWATER, N.J., Nov. 25 The FD... (etravirine) tablets, a non-nucleoside reverse tr...ly NNRTI specifically indicated for use in treatme...ic failure with HIV-1 strains resistant to an NNRT...itional approval is based on 48-week data from two...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Neogen Named to Fortunes List of Fastest Growing Companies 12961 1Neogen Named to Fortunes List of Fastest Growing Companies 12961 2Nick Jonas Joins with Washington Nationals to Support Children with Diatbetes 51244 1Nick Jonas Joins with Washington Nationals to Support Children with Diatbetes 51244 2Video 3A What Are Those Little Red Bumps 3F 51242 1Video 3A What Are Those Little Red Bumps 3F 51242 2Video 3A What Are Those Little Red Bumps 3F 51242 3
...IB1001, an Intravenous Recombinant Factor IX (rFIX...AGUNA NIGUEL, Calif., Feb. 12 Inspiration Biophar...of a Phase 1 clinical trial of IB1001, an intraven...control and prevention of hemorrhagic episodes in ...the market for therapies to treat this disorder is...
...EUSAPharma (formerly Cytogen) Posts Positive Phase...ith Velcade for the Treatment of Relapsed or Refra... Quadramet (153 Samarium-lexidronam) is a radi...ally bone cancer, and is used to treat pain caused...bone. Velcade (bortezomib) is approved for th...
Other Medicine Technology:Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B 2Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results 2
7121B Sony Medical Monitor
Panoview Plus Arthroscopes
A1 Single-Chip Camera
Arthroscope
Medicine Products: